• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常月经周期以及服用低雌激素口服避孕药的女性体内蛋白S的水平。

Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.

作者信息

Jespersen J, Nielsen M T

机构信息

Department of Clinical Chemistry, Ribe County Hospital, Esbjerg, Denmark.

出版信息

Gynecol Obstet Invest. 1989;28(2):82-6. doi: 10.1159/000293521.

DOI:10.1159/000293521
PMID:2529199
Abstract

Total protein S, a coagulation regulating protein, was determined by an electroimmunoassay in samples of plasma collected during one menstrual or hormone-induced cycle in 15 young women and 11 women using oral contraceptives with 30 micrograms ethinyl estradiol and 150 micrograms levonorgestrel. Distinct individual levels caused the with-in-group variations of plasma total protein S to be larger than the individual variations. There was no statistically significant difference between the groups, but in the hormone group there was a slight but statistically significant decrease during the hormone-induced cycle.

摘要

总蛋白S是一种凝血调节蛋白,通过电免疫分析法对15名年轻女性和11名服用含30微克炔雌醇和150微克左炔诺孕酮口服避孕药的女性在一个月经周期或激素诱导周期内采集的血浆样本进行检测。个体水平的差异导致血浆总蛋白S组内变异大于个体变异。两组之间无统计学显著差异,但在激素组中,激素诱导周期内有轻微但统计学显著的下降。

相似文献

1
Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.正常月经周期以及服用低雌激素口服避孕药的女性体内蛋白S的水平。
Gynecol Obstet Invest. 1989;28(2):82-6. doi: 10.1159/000293521.
2
Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.左炔诺孕酮和炔雌醇以一种三相(Trionetta)和一种单相(Neovletta)剂型给药时的避孕可接受性比较。
Contraception. 1983 May;27(5):439-52. doi: 10.1016/0010-7824(83)90041-0.
3
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.四种口服避孕药配方与一种避孕阴道环的代谢及临床效果比较。
Am J Obstet Gynecol. 1980 Apr 1;136(7):920-31. doi: 10.1016/0002-9378(80)91052-2.
4
Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.服用低剂量三相口服避孕药的女性凝血和抗凝的变化:一项为期12个月的对照比较临床试验。
Am J Obstet Gynecol. 1992 Nov;167(5):1255-61. doi: 10.1016/s0002-9378(11)91697-4.
5
Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.正常月经周期及服用低雌激素口服避孕药女性血浆优球蛋白纤溶活性的序贯研究。
Gynecol Obstet Invest. 1983;15(5):266-74. doi: 10.1159/000299420.
6
Contraception in older woman.老年女性的避孕
Contraception. 1993 Mar;47(3):229-39. doi: 10.1016/0010-7824(93)90040-e.
7
The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.低剂量复方口服避孕药对月经失血及铁状态的影响。
Contraception. 1992 Oct;46(4):327-34. doi: 10.1016/0010-7824(92)90095-b.
8
A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.一项关于两种三相口服避孕药对血脂影响的两年临床研究。
Int J Fertil Menopausal Stud. 1994 Sep-Oct;39(5):283-91.
9
Cycle control with triphasic norgestimate and ethinyl estradiol, a new oral contraceptive agent.使用三相诺孕酯和炔雌醇进行周期控制,一种新型口服避孕药。
Acta Obstet Gynecol Scand Suppl. 1992;156:22-6. doi: 10.3109/00016349209156511.
10
Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.含低剂量乙炔雌二醇和d,l-炔诺孕酮的三相口服避孕药对青春期后痤疮中轻度高雄激素活性的抑制作用。
J Clin Endocrinol Metab. 1990 Jul;71(1):8-14. doi: 10.1210/jcem-71-1-8.

引用本文的文献

1
Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease.血浆对活化蛋白C的抵抗作用调节缺血性心脏病患者溶栓诱导的凝血激活。
Heart. 1997 Feb;77(2):122-7. doi: 10.1136/hrt.77.2.122.